Healthcare Sales & Marketing Network News: Betaferon

Searching News Database: Betaferon

HSMN NewsFeed - 15 Sep 2008
Betaseron(R) to Offer the Thinnest Needle in Multiple Sclerosis
Biopharmaceuticals Drug Delivery Neurology

HSMN NewsFeed - 23 Nov 2006
Betaferon(R) Approved in Australia for Earliest Stages of Multiple Sclerosis
Biopharmaceuticals Regulatory Neurology

HSMN NewsFeed - 28 Sep 2006
New Study: AVONEX(R), The Most Prescribed Multiple Sclerosis Treatment Worldwide, Demonstrates Superior Adherence
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Jun 2006
Betaferon(R) Approved in Europe as a First-Line Treatment for the Earliest Stages of Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 4 Apr 2006
Sixteen-Year Follow-up Study Reinforces Betaseron(R) Long-Term Efficacy, Safety and Tolerability in Multiple Sclerosis
Biopharmaceuticals Neurology

Return to NewsFeed

Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 9 additional stories matching:
Betaferon
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.